Showing results (421-430 of 550) with videos related to

Sort By:
Pageof 55
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 27, 2004
Disposition of a novel and potent alpha(v)beta3 antagonist in animals, and extrapolation to manT Prueksaritanont, C Fernandez-Metzler, Y Meng, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 16, 2016
[Evaluation of physical function for the end-stage osteoarthritis patient waiting for the total knee replacement]Z C Li, L Jiang, S Zhang, et al.
The Journal of Biological Chemistry|May 18, 1999
The ankyrin repeat-containing adaptor protein Tvl-1 is a novel substrate and regulator of Raf-1J H Lin, A Makris, C McMahon, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Time- and dose-dependent pharmacokinetics of L-754,394, an HIV protease inhibitor, in rats, dogs and monkeysJ H Lin, M Chiba, I W Chen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 16, 2014
Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signalingW Y Liang, X Y Zhu, J W Zhang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 20, 2025
[Analysis of clinical characteristics in 4 pediatric cases of glycogen storage disease type Ⅸa]B Q Huang, C H Wang, M L Liu, et al.
Biochemical and Biophysical Research Communications|September 28, 2000
Norcantharidin-induced post-G(2)/M apoptosis is dependent on wild-type p53 geneC Y Hong, S C Huang, S K Lin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1995
Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urineS K Balani, B H Arison, L Mathai, et al.
Zhonghua Yi Xue Za Zhi|March 25, 2021
[Effects of neuromuscular exercise therapy on the joint stability of patients with knee osteoarthritis]K Wang, Y F Chen, H B Wang, et al.
Pageof 55